In gastric cancer models, VEGF-C induced by TGF-β1 signaling enhances tumor-induced lymphangiogenesis, and TGF-β1 receptor inhibitor suppresses tumor progression and lymphangiogenesis [102]. Here, VEGFC is linked to gastric cancer.